{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:31:25Z","timestamp":1791153085036,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4409,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01-057877"],"award-info":[{"award-number":["P01-057877"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.fertnstert.2009.11.031","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T00:55:01Z","timestamp":1263516901000},"page":"2668-2673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells"],"prefix":"10.1016","volume":"93","author":[{"given":"Xia","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Coon V.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Wiehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar E.","family":"Bulun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.11.031_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.AOG.0000154161.03418.e3","article-title":"Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study","volume":"105","author":"Wise","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ogc.2005.12.001","article-title":"Steroid hormones and leiomyomas","volume":"33","author":"Marsh","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00006250-199404000-00011","article-title":"Hysterectomy in the United States, 1988\u20131990","volume":"83","author":"Wilcox","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpobgyn.2008.03.001","article-title":"Medical management of fibroids","volume":"22","author":"Sankaran","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.48.1.129","article-title":"RU486 (mifepristone): mechanisms of action and clinical uses","volume":"48","author":"Cadepond","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0022-4731(88)90007-6","article-title":"Screening of anti-progestagens by receptor studies and bioassays","volume":"31","author":"Kloosterboer","year":"1988","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0039-128X(84)80027-6","article-title":"New steroids with antiprogestational and antiglucocorticoid activities","volume":"44","author":"Neef","year":"1984","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.pa.36.040196.000403","article-title":"Antiprogestins: mechanism of action and contraceptive potential","volume":"36","author":"Spitz","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2009.11.031_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/humrep\/9.suppl_1.12","article-title":"History and perspectives of antiprogestins from the chemist's point of view","volume":"9","author":"Teutsch","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.AOG.0000127622.63269.8b","article-title":"Systematic review of mifepristone for the treatment of uterine leiomyomata","volume":"103","author":"Steinauer","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib11","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1517\/14656566.9.14.2487","article-title":"Selective progesterone receptor modulators 3: use in oncology, endocrinology and psychiatry","volume":"9","author":"Benagiano","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-4827(87)90282-5","article-title":"Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes","volume":"173","author":"Busso","year":"1987","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-4731(86)90242-6","article-title":"Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids","volume":"25","author":"Gagne","year":"1986","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(01)00743-2","article-title":"CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914","volume":"188","author":"Attardi","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib16","unstructured":"Repros Therapeutics, Inc. Available from: http:\/\/www.reprosrx.com\/proellex.html[Last accessed 21 December 2009]."},{"key":"10.1016\/j.fertnstert.2009.11.031_bib17","first-page":"1716","article-title":"Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro","volume":"130","author":"Rossi","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib18","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1210\/jc.2008-2327","article-title":"High aromatase expression in uterine leiomyoma tissues of African-American women","volume":"94","author":"Ishikawa","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib20","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1210\/jc.2007-0725","article-title":"Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells","volume":"92","author":"Yin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib21","first-page":"293","article-title":"Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone","volume":"82","author":"Matsuo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/nar\/19.6.1227","article-title":"Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells","volume":"19","author":"Klein-Hitpass","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.steroids.2003.08.007","article-title":"Progesterone antagonists and progesterone receptor modulators: an overview","volume":"68","author":"Spitz","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0039-128X(00)00194-X","article-title":"Progesterone receptor modulators and progesterone antagonists in women's health","volume":"65","author":"Spitz","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-6147(99)01292-4","article-title":"Poly (ADP-ribose) polymerase, nitric oxide and cell death","volume":"20","author":"Pieper","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbrc.2004.06.035","article-title":"Bcl-2 protects against Abeta(25-35)-induced oxidative PC12 cell death by potentiation of antioxidant capacity","volume":"320","author":"Jang","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib28","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1093\/emboj\/cdg470","article-title":"An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation","volume":"22","author":"Fernandez-Zapico","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib29","unstructured":"Repros Therapeutics, Inc. Available from http:\/\/www.drugs.com\/clinical_trials\/repros-therapeutics-inc-announces-proellex-shows-no-adverse-cardiac-pilot-trial-4237.html[Last accessed 21 December 2009]."},{"key":"10.1016\/j.fertnstert.2009.11.031_bib30","first-page":"4092","article-title":"Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment","volume":"83","author":"Englund","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib31","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1210\/jc.2009-1286","article-title":"Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells","volume":"94","author":"Luo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib32","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","article-title":"Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells","volume":"21","author":"Xu","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gan004","article-title":"Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells","volume":"14","author":"Xu","year":"2008","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/den025","article-title":"Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer","volume":"23","author":"Morikawa","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719107311464","article-title":"Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells","volume":"14","author":"Ohara","year":"2007","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2009.11.031_bib36","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1210\/jc.2006-0898","volume":"92","author":"Sasaki","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209041119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209041119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:38:39Z","timestamp":1758008319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209041119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0015028209041119"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.11.031","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}